Characteristics of Adults with Migraine, Al Ain, United Arab Emirates
DOI:
https://doi.org/10.54536/ajmsi.v5i1.4660Keywords:
Acute Acute, Chronic Migraine, Comorbidities, Demographics, Episodic Migraine, Preventative, Retrospective StudyAbstract
Migraine Is a common neurological disease affects millions of individuals worldwide, categorized into episodic migraine (EM) and chronic migraine (CM).
The aim of this study is to evaluate the characteristics of migraine, EM and CM treatments, and associated comorbidities, in Alain city adults’ population. A retrospective study was conducted on adult people at Mediclinic Al Ain Hospital, from 1 January 2022 to 31 October 2022. descriptive statistics were done on data collected from medical records. Out of 343 patients 212 met the inclusion and exclusion criteria and included in the study, The mean age of patients was 37.94(SD 9.784) AND 95%CI (36.61-39.26). Fifty patients (23.6%) have chronic migraine and 162 patients (76.4%) have episodic migraine, 44 females have CM (26.8%) and 120 females have EM (73.2%). The most common comorbidities, (>10% of individuals) in both migraine groups were vitamin D-deficiency in 62 (29.2%), gastroesophageal reflux 47 patients (22.2 %) and hypertension in 26 patients (12.3 %). most of the patients used acute and preventative therapies. Patients of both groups displayed characteristics and medication use patterns consistent with other reports. screening vitamin D and esophageal reflux should be encouraged for adults presented with migraine headache.
Downloads
References
Vos, T., Abajobir, A. A., Abate, K. H., et al. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2
Ashina, M. (2020). Migraine. New England Journal of Medicine, 383(19), 1866–1876. https://doi.org/10.1056/NEJMra1915327
Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202
Saylor, D., & Steiner, T. (2018). The global burden of headache. Seminars in Neurology, 38(2), 182–190. https://doi.org/10.1055/s-0038-1646946
Stovner, L. J., Nichols, E., Steiner, T. J., et al. (2018). Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 954–976. https://doi.org/10.1016/S1474-4422(18)30322-3
Lyngberg, A. C., Rasmussen, B. K., Jørgensen, T., & Jensen, R. (2005). Incidence of primary headache: A Danish epidemiologic follow-up study. American Journal of Epidemiology, 161(11), 1066–1073. https://doi.org/10.1093/aje/kwi139
Stewart, W. F., Wood, C., Reed, M. L., Roy, J., & Lipton, R. B. (2008). Cumulative lifetime migraine incidence in women and men. Cephalalgia, 28(11), 1170–1178. https://doi.org/10.1111/j.1468-2982.2008.01666.x
Jette, N., Patten, S., Williams, J., Becker, W., & Wiebe, S. (2008). Comorbidity of migraine and psychiatric disorders—A national population-based study. Headache: The Journal of Head and Face Pain, 48(4), 501–516. https://doi.org/10.1111/j.1526-4610.2007.00993.x
Buse, D. C., Greisman, J. D., Baigi, K., & Lipton, R. B. (2020). Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: Results of the migraine in America symptoms and treatment (MAST) study. The Journal of Headache and Pain, 21(1), 23. https://doi.org/10.1186/s10194-020-1084-y
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68(5), 343–349. https://doi.org/10.1212/01.wnl.0000252808.97649.21
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2012). Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache: The Journal of Head and Face Pain, 52(10), 1456–1470. https://doi.org/10.1111/j.1526-4610.2012.02223.x
Linde, M., Gustavsson, A., Stovner, L. J., et al. (2012). The cost of headache disorders in Europe: The Eurolight project. European Journal of Neurology, 19(5), 703–711. https://doi.org/10.1111/j.1468-1331.2011.03612.x
Stokes, M., Becker, W. J., Lipton, R. B., et al. (2011). Cost of health care among patients with chronic and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache: The Journal of Head and Face Pain, 51(7), 1058–1077. https://doi.org/10.1111/j.1526-4610.2011.01945.x
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Yaser M. Al Msalmeh
This work is licensed under a Creative Commons Attribution 4.0 International License.
